Omalizumab

Brand name: Xolair

Rank #160 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$98.9M

Total Cost

Share:

30,451

Total Claims

$98.9M

Total Cost

1,159

Prescribers

$3,248

Cost per Claim

368

Beneficiaries

31,016

30-Day Fills

$85K

Avg Cost/Provider

26

Avg Claims/Provider

Share of Medicare Part D Spending

0.04%

of total Medicare Part D spending

$98.9M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $98.9M total

🔎 Data Overview

💰

At $3,248 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.

👤

Average cost of $268,742 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Omalizumab

#ProviderSpecialtyLocationClaimsCost
1Michael NewanPulmonary DiseaseSt Petersburg, FL432$2.9M
2David TottoriAllergy/ ImmunologyLas Vegas, NV320$975K
3Valery ChuPharmacistBrooklyn, NY301$803K
4Pallak AgarwalInternal MedicineWyomissing, PA145$633K
5Bradley ChippsPulmonary DiseaseSacramento, CA189$530K
6Anne Marie HollyPhysician AssistantRochester, NY153$450K
7Shijun XiAllergy/ ImmunologyLos Angeles, CA54$414K
8Gregory CaliPulmonary DiseaseDunmore, PA88$410K
9Golda HudesAllergy/ ImmunologyBronx, NY129$385K
10Kevin LindgrenAllergy/ ImmunologyOak Park, IL97$354K
11Sean BradyAllergy/ ImmunologyWilliamsville, NY110$347K
12Jordan ScottAllergy/ ImmunologyLeominster, MA63$342K
13Marc CromieAllergy/ ImmunologyChattanooga, TN115$341K
14James JacksonInternal MedicineFrankfort, KY108$336K
15Andrey PavlovPulmonary DiseaseSpringfield, MA103$329K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
157Ubrogepant (Ubrelvy)$100.6M75,781
158Darunavir/Cobicistat (Prezcobix)$99.7M38,374
159Tocilizumab (Actemra)$99.5M24,891
160Omalizumab (Xolair)$98.9M30,451
161Brimonidine Tartrate (Alphagan P)$98.8M988,570
162Dexlansoprazole (Dexlansoprazole Dr)$98.7M275,116
163Interferon Beta-1a (Avonex)$98.3M11,314

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology